1. Home
  2. RNA vs CCOI Comparison

RNA vs CCOI Comparison

Compare RNA & CCOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNA
  • CCOI
  • Stock Information
  • Founded
  • RNA 2012
  • CCOI 1999
  • Country
  • RNA United States
  • CCOI United States
  • Employees
  • RNA N/A
  • CCOI N/A
  • Industry
  • RNA Biotechnology: Pharmaceutical Preparations
  • CCOI Telecommunications Equipment
  • Sector
  • RNA Health Care
  • CCOI Consumer Discretionary
  • Exchange
  • RNA Nasdaq
  • CCOI Nasdaq
  • Market Cap
  • RNA 4.4B
  • CCOI 3.8B
  • IPO Year
  • RNA 2020
  • CCOI N/A
  • Fundamental
  • Price
  • RNA $28.92
  • CCOI $72.60
  • Analyst Decision
  • RNA Strong Buy
  • CCOI Buy
  • Analyst Count
  • RNA 10
  • CCOI 11
  • Target Price
  • RNA $65.80
  • CCOI $82.00
  • AVG Volume (30 Days)
  • RNA 1.4M
  • CCOI 439.8K
  • Earning Date
  • RNA 02-26-2025
  • CCOI 02-27-2025
  • Dividend Yield
  • RNA N/A
  • CCOI 5.48%
  • EPS Growth
  • RNA N/A
  • CCOI N/A
  • EPS
  • RNA N/A
  • CCOI 0.82
  • Revenue
  • RNA $10,117,000.00
  • CCOI $976,013,000.00
  • Revenue This Year
  • RNA N/A
  • CCOI $19.45
  • Revenue Next Year
  • RNA N/A
  • CCOI $3.48
  • P/E Ratio
  • RNA N/A
  • CCOI $88.57
  • Revenue Growth
  • RNA N/A
  • CCOI 24.03
  • 52 Week Low
  • RNA $9.93
  • CCOI $50.80
  • 52 Week High
  • RNA $56.00
  • CCOI $86.76
  • Technical
  • Relative Strength Index (RSI)
  • RNA 37.85
  • CCOI 39.80
  • Support Level
  • RNA $26.74
  • CCOI $72.06
  • Resistance Level
  • RNA $31.06
  • CCOI $73.78
  • Average True Range (ATR)
  • RNA 1.77
  • CCOI 2.14
  • MACD
  • RNA 0.24
  • CCOI -0.10
  • Stochastic Oscillator
  • RNA 37.85
  • CCOI 20.67

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.

About CCOI Cogent Communications Holdings Inc.

Cogent carries over one fifth of the world's internet traffic over its network and is a broadband provider for businesses. Cogent's corporate customers are in high-rise office buildings; the firm provides them with two types of connections: dedicated internet access, which connects them to the internet, and virtual private networking, which offers an internal network for employees in different locations. Cogent's corporate customers are exclusively in North America and account for over half of the firm's revenue. Cogent's netcentric customers include internet service providers and content providers, to which Cogent provides internet transit. They hand traffic to Cogent in data centers and rely on Cogent to deliver it. About half of netcentric revenue is from outside the US.

Share on Social Networks: